Use of paclitaxel in patients with pre-existing cardiomyopathy: a review of our experience.
about
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells.The paradox of the first cycle of chemotherapy-transient improvement of contractility and diastolic function after the first cycle of anthracycline-based chemotherapy: a prospective clinical trial.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice GuidelinesCardio-oncology: A Focus on CardiotoxicityThe Pathogenesis and Therapies of Striated Muscle Laminopathies
P2860
Use of paclitaxel in patients with pre-existing cardiomyopathy: a review of our experience.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Use of paclitaxel in patients ...... y: a review of our experience.
@ast
Use of paclitaxel in patients ...... y: a review of our experience.
@en
Use of paclitaxel in patients ...... y: a review of our experience.
@nl
type
label
Use of paclitaxel in patients ...... y: a review of our experience.
@ast
Use of paclitaxel in patients ...... y: a review of our experience.
@en
Use of paclitaxel in patients ...... y: a review of our experience.
@nl
prefLabel
Use of paclitaxel in patients ...... y: a review of our experience.
@ast
Use of paclitaxel in patients ...... y: a review of our experience.
@en
Use of paclitaxel in patients ...... y: a review of our experience.
@nl
P2093
P2860
P356
P1476
Use of paclitaxel in patients ...... y: a review of our experience.
@en
P2093
P2860
P304
P356
10.1002/IJC.1295
P577
2001-07-01T00:00:00Z